GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently becoming a significant focus in healthcare studies, largely due to its impressive impact on controlling conditions such as second type diabetes and excess body fat. New studies have revealed that in addition to glucose management, GLP-1 drugs offer potential for circulatory we